Word: marketization
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...with W magazine that trading nylon for celluloid was a terrible idea. His chagrin is understandable: the DuPont stock, worth $8.8 billion when Seagram sold it in 1995 to pay for its $5.7 billion purchase of Universal, has soared about $9 billion in value. Seagram's stock lags the market, in part because of doubts about Universal, which last year had operating income of $242 million on sales of about $5.6 billion. "So far, it looks like we missed the boat," Edgar Sr. said, quickly adding, "I supported my son then, and I support...
...complains Dr. Domeena Renshaw, a psychiatrist who directs the Loyola Sex Therapy Clinic outside Chicago. "They think Viagra is magic, just like they thought the G spot worked like a garage-door opener." In the wake of fen/phen and Redux, the diet-drug treatments that were pulled from the market last year after it was learned that they could damage heart valves, caution would be advisable with Viagra. But so far the side effects seem comparatively slight and manageable: chiefly headache, flushed skin, upset stomach and curious vision distortions involving the color blue. Pfizer, leaving nothing to chance, has even...
From a drug manufacturer's point of view, this burgeoning of the potential market has coincided quite nicely with the development of pharmaceutical treatments. (At least two more impotence pills are in the pipeline from different companies.) Before Viagra, the most promising therapies involved putting gel suppositories in the urethra and injecting drugs directly into the base of the penis. The downside is not hard to grasp. "You can imagine the look most patients gave when I told them they would have to stick a small needle into the most sensitive portion of their body," says University of Chicago urologist...
...magazines for spurious Spanish fly, hard-on creams and the like) that drug companies have only recently turned their attention to sexual dysfunction. This would account for the tone adopted by Pfizer chairman and CEO William Steere even as he figuratively licks his chops over the potential market in "aging baby boomers." He is careful to point out that "quality-of-life drugs are gene-based just like those for serious medical conditions. In areas like impotence, aging skin, baldness and obesity, the science is just as profound as if you were working in cancer, asthma or anti-infectives...
...much better. Much firmer, stronger erections. And the orgasm is much more explosive." So pleased has Cannata been with the results that he was inspired, he says, to go out and buy a sports car not long after beginning the drug--indicating, perhaps, a soon-to-boom, Viagra-inspired market for souped-up cars, Aramis, oversize stereo equipment and other accoutrements of the virile life-style...